ArticleJournal for immunotherapy of cancer2024

MHC class I and II-deficient humanized mice are suitable tools to test the long-term antitumor efficacy of immune checkpoint inhibitors and T-cell engagers.

Iñaki Eguren-Santamaria et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.